RxDoctor Payments Data

Konstantin Kovtun, MD

Radiation Oncology · Baton Rouge, LANPI 1528406832

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,317 of the $3,455 with a category attached, or 67.1%. 11 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 44.4% of the total. 2025 is the largest year on record at $1,533, more than ten times the $64 reported in 2019. Among radiation oncology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,455in general payments, 2019–2025

Across 31 payments — averaging $111.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$2K
  • Elekta, Inc.$1K
  • Medtronic$138
  • Varian Medical Systems, Inc.$134
  • Novartis$72
  • E.r. Squibb & Sons, L.L.C.$41
  • plus $112 from 5 others

What the payments were for

  • Travel & lodging$2,31767%
  • Food & beverage$1,13833%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,455 in reported general payments places this provider in the 90th percentile of 58 radiation oncology providers in Louisiana.

See all radiation oncology providers in Louisiana

Medicare billing

Part B allowed, 2024
$2,350,618
Medicare patients
567
Services billed
38,337

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl51$530
Memantine Hcl20$476
Dexamethasone13$219
Lorazepam32$52

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →